Infleqtion, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Infleqtion, Inc. (INFQ) on May 14, 2026, reporting events occurring on May 8, 2026. The filing addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel appointments and related contractual agreements.
Material Changes
- Director Appointment: Nicholas Johnson was appointed as a Class III director, with a term expiring at the 2029 annual meeting of stockholders.
- Independence Status: Mr. Johnson is not considered independent under NYSE listing standards due to his role as Managing Director of M. Klein & Company, an affiliate of Archimedes Advisor Group, which has an Advisory Agreement with the Company.
- Committee Assignments: Due to his non-independent status, Mr. Johnson has not been appointed to any standing committees of the Board.
Guidance, Outlook, and Related Agreements
The appointment was made pursuant to Section 8.09 of the Merger Agreement between Churchill Capital Corp X and ColdQuanta, Inc. (d/b/a Infleqtion), granting Churchill Sponsor X LLC the right to designate one Class III director.
Advisory Agreement Details:
- Parties: Infleqtion, Inc. and M. Klein & Company (the "Advisor").
- Services: Financial advisory, strategy consulting, business development, and investor relations.
- Compensation: A quarterly fee of $250,000 for the term of the agreement (two years from Closing).
- Additional Fees: The Advisor is entitled to 5% of total underwriting fees for capital markets financings and 3% of gross proceeds from strategic investments, contingent on the Company retaining the Advisor for such transactions.
- Director Compensation: Mr. Johnson will not receive compensation under the Company's Non-Employee Director Compensation Policy while the Advisory Agreement is in effect.
Investor Verification Checklist
- Verify the terms of the Merger Agreement (Exhibit 2.1 to the February 17, 2026, 8-K) regarding director designation rights.
- Review the Advisory Agreement (Exhibit 10.4 to the February 17, 2026, 8-K) for specific conditions on the $250,000 quarterly fee and performance-based fees.
- Confirm the impact of the non-independent director appointment on Board committee composition and governance standards.
- Check subsequent filings for any changes to the Advisory Agreement or the appointment of Mr. Johnson to standing committees.